Korro Bio, Inc. · 1 week ago
Associate Director, Clinical Scientist
Cambridge, MA
Full-time
Onsite
Lead/Staff, Director/Executive
$173K/yr - $210K/yr
2+ years expKorro Bio, Inc. is a biopharmaceutical company focused on developing innovative genetic medicines. The Clinical Scientist will collaborate with the clinical development department to design and implement clinical development plans, ensuring the successful execution of clinical trials and effective communication of trial data.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Contributing to the design of clinical trials and writing/review of protocol concepts, full study protocols, and other critical study documents (Investigator Brochures, IND submissions, Clinical Study Reports, etc.)
Clinical study data review, data cleaning and performing data analyses
Delivering high quality presentations on company technology, investigational agents and/or clinical study issues to investigators and clinical site staff
Providing guidance and/or training for external personnel/parties involved in clinical studies
Contribute to creation of electronic database, IRT, and associated training documents and review data completeness and fidelity throughout study conduct
Monitoring for analyses of emerging safety/tolerability
Provide education support for internal company stakeholders
Provide input and support to the Research and Discovery organization as needed
Work collaboratively with the translational medicine group on the identification, selection, and validation of biomarkers to support the clinical development plans
Facilitate, assist and/or participate in the preparation of clinical study manuscripts with Investigators, internal personnel, and medical writers
Maintain expertise in the therapeutic area; review scientific journals, attend scientific and key technical meetings and partner with company medical, research and translational teams
Support the organization of expert panels and advisory board meetings to provide input into the clinical plan, study design or data
Collaborating with patient advocacy groups, external investigators, and other stakeholders as needed
Support clinical development team on developing the clinical development strategy
Qualification
Required
PhD or PharmD is highly desired
A minimum of 2–5 years of Clinical Scientist experience in the biotechnology and/or pharmaceutical industry
Comprehensive knowledge of the drug development process
Proficient knowledge of GCP/ICH, study design, statistics and clinical operations is required
Proven experience with clinical data review databases
Excellent verbal, written, and interpersonal communication skills, with the ability to collaborate effectively across functions and all job levels
Proven scientific writing skills, with the ability to evaluate, interpret, and present complex data clearly and effectively
Creativity and/ or ability to put innovative approaches into practice in clinical development
Strong sense of teamwork; ability to lead team activities
Exemplary critical thinking, problem solving and decision-making skills
Adaptable, flexible, willingness to adjust to multiple demands and shifting priorities; ability to meet day-to-day challenges with confidence and professionalism
Potential for travel (up to 20%)
Preferred
Experience in rare diseases and/or early-stage development is a plus
Benefits
Medical
Dental
Vision
401(k) retirement plan
Life insurance
A dependent care flexible spending account
A Company-funded health savings account
Free parking
Company
Korro Bio, Inc.
Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients.
51-200 employees
H1B Sponsorship
Korro Bio, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2022 (1)
Funding
Current Stage
Public CompanyTotal Funding
$277.5MKey Investors
Deep Track CapitalEventideWu Capital
2024-04-18Post Ipo Equity· $70M
2023-11-06IPO
2022-01-05Series B· $116M
Leadership Team
Ram Aiyar
Chief Executive Officer
Todd Chappell
Chief Operating Officer
Recent News
2026-01-09
New Enterprise Associates
2026-01-05
Genetic Engineering News
2025-11-19
Company data provided by crunchbase